Our comprehensive approach combines medical expertise with cutting-edge peptide therapy to help you achieve peak performance while maintaining optimal health and safety
Current Research & Industry Status (2026) The scientific community views these two peptides as the foundational pillars of regenerative peptide research
BPC-157 for GERD Acid Reflux Research Mechanisms & Data A 2021 study published in Biomedicines found that BPC-157 accelerated gastric ulcer healing in rodent models by upregulating vascular endothelial growth factor (VEGF) and modulating nitric oxide pathways
1-30C, away from light
For researchers running a standard titration schedule, 2mL is the sweet spot between concentration and practicality
How BPC-157 Reduces Inflammation: Potent but Site-Focused Repair BPC-157, when administered via distant systemic injection (such as subcutaneous in the abdomen), circulates throughout the body yet still produces pronounced localized reduction in inflammation at specific injury or damaged sites because its pleiotropic mechanismssuch as balancing nitric oxide signaling, upregulating VEGF and growth factors, downregulating pro-inflammatory cytokines (TNF-, IL-6), and shifting macrophages from pro-inflammatory M1 to reparative M2 phenotypesare context-dependent and preferentially engage in tissues under stress or injury, where repair pathways are already activated, effectively amplifying healing and resolving excessive inflammation precisely where needed without broadly suppressing it elsewhere
